1. Home
  2. PCRX vs RDW Comparison

PCRX vs RDW Comparison

Compare PCRX & RDW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • RDW
  • Stock Information
  • Founded
  • PCRX 2006
  • RDW 2020
  • Country
  • PCRX United States
  • RDW United States
  • Employees
  • PCRX N/A
  • RDW N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • RDW Military/Government/Technical
  • Sector
  • PCRX Health Care
  • RDW Industrials
  • Exchange
  • PCRX Nasdaq
  • RDW Nasdaq
  • Market Cap
  • PCRX 1.2B
  • RDW 1.2B
  • IPO Year
  • PCRX 2011
  • RDW N/A
  • Fundamental
  • Price
  • PCRX $22.76
  • RDW $8.54
  • Analyst Decision
  • PCRX Buy
  • RDW Buy
  • Analyst Count
  • PCRX 5
  • RDW 7
  • Target Price
  • PCRX $32.40
  • RDW $17.21
  • AVG Volume (30 Days)
  • PCRX 479.4K
  • RDW 9.6M
  • Earning Date
  • PCRX 11-05-2025
  • RDW 11-05-2025
  • Dividend Yield
  • PCRX N/A
  • RDW N/A
  • EPS Growth
  • PCRX N/A
  • RDW N/A
  • EPS
  • PCRX N/A
  • RDW N/A
  • Revenue
  • PCRX $705,848,000.00
  • RDW $261,353,000.00
  • Revenue This Year
  • PCRX $7.36
  • RDW $34.83
  • Revenue Next Year
  • PCRX $10.07
  • RDW $41.86
  • P/E Ratio
  • PCRX N/A
  • RDW N/A
  • Revenue Growth
  • PCRX 2.25
  • RDW N/A
  • 52 Week Low
  • PCRX $16.00
  • RDW $6.61
  • 52 Week High
  • PCRX $27.64
  • RDW $26.66
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 35.28
  • RDW 42.51
  • Support Level
  • PCRX $24.31
  • RDW $8.62
  • Resistance Level
  • PCRX $26.05
  • RDW $9.91
  • Average True Range (ATR)
  • PCRX 0.82
  • RDW 0.74
  • MACD
  • PCRX -0.20
  • RDW -0.08
  • Stochastic Oscillator
  • PCRX 18.36
  • RDW 1.34

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About RDW Redwire Corporation

Redwire Corp is engaged in mission-critical space solutions and reliable components for the next-generation space economy. It assists its customers in solving the complex challenges of future space missions and industries. The company's space infrastructure offerings include a broad array of modern products and services, which have been enabling space missions. The company's plan enables it to combine decades of flight heritage with a culture creating new technologies that are the building blocks of space infrastructure for government and commercial customers.

Share on Social Networks: